Literature DB >> 26319262

How Do Quality-of-Life and Gastrointestinal Symptoms Differ Between Post-cholecystectomy Patients and the Background Population?

Viktor Wanjura1, Gabriel Sandblom2.   

Abstract

BACKGROUND: Previous studies have indicated a correlation between indication for cholecystectomy and long-term gastrointestinal quality-of-life (QoL). The aim of the present study was to compare QoL in a post-cholecystectomy cohort with the background population and with historical controls.
METHODS: A post-cholecystectomy study group (on average 4 years after cholecystectomy) was compared with a control group from the background population using the Gastrointestinal Quality-of-Life Index (GIQLI). EQ-5D scores were compared with expected scores derived from recent historical data.
RESULTS: The post-cholecystectomy study group (N = 451) had better QoL measured by the EQ-5D compared with historical controls (p < 0.001), similar total GIQLI scores as the control group (N = 390), but scored worse on the GIQLI gastrointestinal symptoms subscale score (p < 0.001). The results include an item-by-item breakdown of the GIQLI questionnaire where the scores for diarrhea, bowel urgency, bloating, regurgitation, abdominal pain, flatus, fullness, nausea, uncontrolled stools, belching, heartburn, restricted eating, and bowel frequency were found to be significantly lower (i.e. worse) in the post-cholecystectomy cohort than in the control group. The opposite was true for relationships, endurance, sexual life, physical strength, feeling fit, not being frustrated by illness, and being able to carry out leisure activities, i.e. items related to general performance and well-being.
CONCLUSIONS: In this study, QoL after cholecystectomy was good, but there was an increased prevalence of gastrointestinal symptoms compared to the background population.

Entities:  

Mesh:

Year:  2016        PMID: 26319262     DOI: 10.1007/s00268-015-3240-0

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  19 in total

Review 1.  Persistent and de novo symptoms after cholecystectomy: a systematic review of cholecystectomy effectiveness.

Authors:  Mark P Lamberts; Marjolein Lugtenberg; Maroeska M Rovers; Anne J Roukema; Joost P H Drenth; Gert P Westert; Cornelis J H M van Laarhoven
Journal:  Surg Endosc       Date:  2012-10-06       Impact factor: 4.584

2.  Preoperative prediction model of outcome after cholecystectomy for symptomatic gallstones.

Authors:  L Borly; I B Anderson; L Bardram; E Christensen; A Sehested; H Kehlet; P Matzen; J F Rehfeld; P Stage; D B Toftdahl; A Gernow; L Højgaard
Journal:  Scand J Gastroenterol       Date:  1999-11       Impact factor: 2.423

3.  Gastrointestinal quality-of-life after cholecystectomy: indication predicts gastrointestinal symptoms and abdominal pain.

Authors:  Viktor Wanjura; Patrik Lundström; Johanna Osterberg; Ib Rasmussen; Britt-Marie Karlson; Gabriel Sandblom
Journal:  World J Surg       Date:  2014-12       Impact factor: 3.352

4.  Bowel habit after cholecystectomy: physiological changes and clinical implications.

Authors:  J M Fort; F Azpiroz; F Casellas; J Andreu; J R Malagelada
Journal:  Gastroenterology       Date:  1996-09       Impact factor: 22.682

5.  Health-related quality of life by disease and socio-economic group in the general population in Sweden.

Authors:  K Burström; M Johannesson; F Diderichsen
Journal:  Health Policy       Date:  2001-01       Impact factor: 2.980

6.  A 24-year controlled follow-up of patients with silent gallstones showed no long-term risk of symptoms or adverse events leading to cholecystectomy.

Authors:  Malte Schmidt; Trygve Hausken; Inge Glambek; Christoph Schleer; Geir Egil Eide; Karl Søndenaa
Journal:  Scand J Gastroenterol       Date:  2011-04-19       Impact factor: 2.423

7.  Natural history of gallstone disease: Expectant management or active treatment? Results from a population-based cohort study.

Authors:  Davide Festi; Maria Letizia Bacchi Reggiani; Adolfo F Attili; Paola Loria; Paolo Pazzi; Eleonora Scaioli; Simona Capodicasa; Ferdinando Romano; Enrico Roda; Antonio Colecchia
Journal:  J Gastroenterol Hepatol       Date:  2010-04       Impact factor: 4.029

8.  Bowel habits and bile acid malabsorption in the months after cholecystectomy.

Authors:  Gerd H Sauter; Ahmed C Moussavian; Guenther Meyer; Heinrich O Steitz; Klaus G Parhofer; Dieter Jüngst
Journal:  Am J Gastroenterol       Date:  2002-07       Impact factor: 10.864

9.  Diarrhoea after laparoscopic cholecystectomy: incidence and main determinants.

Authors:  Mikhail Fisher; Dean C Spilias; Lien K Tong
Journal:  ANZ J Surg       Date:  2008-06       Impact factor: 1.872

10.  Development of symptoms and complications in individuals with asymptomatic gallstones.

Authors:  I Halldestam; E-L Enell; E Kullman; K Borch
Journal:  Br J Surg       Date:  2004-06       Impact factor: 6.939

View more
  10 in total

1.  Patient-reported outcome measures (PROMs) after laparoscopic cholecystectomy: systematic review.

Authors:  Conor Melly; Gearoid McGeehan; Niall O'Connor; Alison Johnston; Gary Bass; Shahin Mohseni; Claire Donohoe; Magda Bucholc; Michael Sugrue
Journal:  BJS Open       Date:  2022-05-02

Review 2.  A systematic review of patient reported outcome measures (PROMs) and quality of life reporting in patients undergoing laparoscopic cholecystectomy.

Authors:  Prita Daliya; Elizabeth H Gemmill; Dileep N Lobo; Simon L Parsons
Journal:  Hepatobiliary Surg Nutr       Date:  2019-06       Impact factor: 7.293

3.  Rates of Bile Acid Diarrhoea After Cholecystectomy: A Multicentre Audit.

Authors:  Alexia Farrugia; Joseph Anthony Attard; Stuart Hanmer; Stuart Bullock; Siobhan McKay; Marwa Al-Azzawi; Roshneen Ali; Giles Bond-Smith; Ben Colleypriest; Sarah Dyer; Benjamin Masterman; Michael Okocha; Alan Osborne; Rikhilroy Patel; Mahmoud Sallam; Emmanuel Selveraj; Samar Shalaby; Wenrui Sun; Fraser Todd; Joel Ward; Rebecca Windle; Saboor Khan; Nigel Williams; Ramesh P Arasaradnam
Journal:  World J Surg       Date:  2021-05-12       Impact factor: 3.352

4.  Predictors of Diarrhea after Hepatectomy and Its Impact on Gastrointestinal Quality of Life in Living Donors.

Authors:  Szu-Han Wang; Ying-Zi Ming; Ping-Yi Lin; Jiun-Yi Wang; Hui-Chuan Lin; Chia-En Hsieh; Ya-Lan Hsu; Yao-Li Chen
Journal:  PLoS One       Date:  2016-11-18       Impact factor: 3.240

5.  Index admission laparoscopic cholecystectomy for acute cholecystitis restores Gastrointestinal Quality of Life Index (GIQLI) score.

Authors:  Hongyan Yu; Esther Ern-Hwei Chan; Pravin Lingam; Jingwen Lee; Winston Wei Liang Woon; Jee Keem Low; Vishal G Shelat
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2018-02-26

6.  Patient reported outcomes in elective laparoscopic cholecystectomy.

Authors:  Malcolm H W Mak; Woon Ling Chew; Sameer P Junnarkar; Winston W L Woon; Jee-Keem Low; Terence C W Huey; Vishalkumar G Shelat
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2019-02-28

7.  Postcholecystectomy diarrhoea rate and predictive factors: a systematic review of the literature.

Authors:  Alexia Farrugia; Joseph Anthony Attard; Saboor Khan; Nigel Williams; Ramesh Arasaradnam
Journal:  BMJ Open       Date:  2022-02-17       Impact factor: 2.692

8.  Quality of life and psychological and gastrointestinal symptoms after cholecystectomy: a population-based cohort study.

Authors:  Arne Talseth; Tom-Harald Edna; Kristian Hveem; Stian Lydersen; Eivind Ness-Jensen
Journal:  BMJ Open Gastroenterol       Date:  2017-04-01

9.  Postcholecystectomy syndrome: symptom clusters after laparoscopic cholecystectomy.

Authors:  Hongbeom Kim; In Woong Han; Jin Seok Heo; Min Gu Oh; Chi Yeon Lim; Yoo Shin Choi; Seung Eun Lee
Journal:  Ann Surg Treat Res       Date:  2018-08-31       Impact factor: 1.859

Review 10.  The Need for Standardizing Diagnosis, Treatment and Clinical Care of Cholecystitis and Biliary Colic in Gallbladder Disease.

Authors:  Gerard Doherty; Matthew Manktelow; Brendan Skelly; Paddy Gillespie; Anthony J Bjourson; Steven Watterson
Journal:  Medicina (Kaunas)       Date:  2022-03-05       Impact factor: 2.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.